Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alzheimer's Disease
100%
Metabolic
100%
Adiponectin
100%
Memory Deficits
100%
Nonapeptides
100%
Adiponectin Receptor 1 (AdipoR1)
88%
AMP-activated Protein Kinase
33%
Protein Kinase Signaling
33%
Insulin Signaling
22%
Neurodegenerative Diseases
22%
Biochemical Analysis
22%
Brain Tissue
22%
Neuronal Insulin Resistance
22%
Adiponectin Knockout Mice
22%
Potential Therapeutics
11%
Therapeutic Effect
11%
Knockdown
11%
In Vitro Study
11%
Behavioral Studies
11%
Long-term Potentiation
11%
Transgenic
11%
Novel Therapeutics
11%
Knock-in Mouse Model
11%
Downstream Targets
11%
Putative Drug Targets
11%
Overexpressing
11%
Blood-brain Barrier
11%
Novel Therapeutic Targets
11%
Therapeutic Candidates
11%
Neuroprotection
11%
Targeted Agents
11%
Immunohistochemical Analysis
11%
Memory Function
11%
Small Interfering RNA (siRNA)
11%
Brain Metabolism
11%
Alzheimer's Disease Brain
11%
Mechanistic Approach
11%
Synaptic Function
11%
Good Safety
11%
Neuroblastoma SH-SY5Y Cells
11%
Dosage Regimen
11%
Amyloid-β Oligomers
11%
Neuronal Metabolism
11%
Indiana
11%
Osmotin
11%
Golgi Staining
11%
APPPS1
11%
Brain Metabolic Disorders
11%
Staining Test
11%
Neuroscience
Alzheimer's Disease
100%
Adiponectin
100%
Nonapeptide
100%
Adiponectin Receptor 1
88%
In Vivo
33%
AMP-activated Protein Kinase
33%
In Vitro
22%
Neurodegenerative Disorder
22%
Insulin Signaling
22%
Long-Term Potentiation
11%
Metabolic Pathway
11%
Neuroprotection
11%
Staining Technique
11%
Treatment of Alzheimer's Disease
11%
Brain Metabolism
11%
Blood Brain Barrier
11%
Oligomer
11%
Beta Amyloid
11%
Neuroblastoma
11%
Small Interfering RNA
11%
INIS
nervous system diseases
100%
receptors
66%
pep
66%
brain
33%
mice
33%
insulin
33%
proteins
25%
in vivo
25%
kinases
25%
knock-out reactions
25%
amp
25%
humans
16%
tissues
16%
metabolism
16%
in vitro
16%
levels
8%
regulations
8%
safety
8%
interventions
8%
psychological behavior
8%
hypothesis
8%
sweden
8%
blood-brain barrier
8%
indiana
8%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Adiponectin
100%
Nonapeptide
100%
Adiponectin Receptor 1
80%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
30%
Insulin Resistance
20%
Knockout Mouse
20%
Degenerative Disease
20%
Small Interfering RNA
10%
Therapeutic Effect
10%
Neuroprotection
10%
Neuroblastoma
10%
Oligomer
10%
Blood-Brain Barrier
10%
Amyloid Protein
10%
Biochemistry, Genetics and Molecular Biology
Adiponectin
100%
AMP-activated Protein Kinase
20%
Insulin Resistance
13%
Knockout Mouse
13%
Insulin Signaling
13%
Metabolic Pathway
6%
In Vitro Study
6%
In Vivo Study
6%
Transgenics
6%
Brain Metabolism
6%
Blood Brain Barrier
6%
Long Term Potentiation
6%
Amyloid Beta
6%
Drug Dose Regimen
6%
Golgi Stain
6%